{"organizations": [], "uuid": "7b118841975ea455627642f14b7fe63084431dd9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-great-point-partners-opposes-biocr/brief-great-point-partners-opposes-biocryst-pharma-proposed-merger-with-idera-pharma-idUSFWN1Q61F4", "country": "US", "domain_rank": 408, "title": "BRIEF-Great Point Partners Opposes Biocryst Pharma Proposed Merger With Idera Pharma", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-16T21:33:00.000+02:00", "replies_count": 0, "uuid": "7b118841975ea455627642f14b7fe63084431dd9"}, "author": "", "url": "https://www.reuters.com/article/brief-great-point-partners-opposes-biocr/brief-great-point-partners-opposes-biocryst-pharma-proposed-merger-with-idera-pharma-idUSFWN1Q61F4", "ord_in_thread": 0, "title": "BRIEF-Great Point Partners Opposes Biocryst Pharma Proposed Merger With Idera Pharma", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "biocryst pharma proposed merger with idera pharma", "sentiment": "negative"}, {"name": "biocryst pharmaceutical board", "sentiment": "none"}, {"name": "idera pharma reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 16, 2018 / 7:36 PM / Updated 8 minutes ago BRIEF-Great Point Partners Opposes Biocryst Pharma Proposed Merger With Idera Pharma Reuters Staff Feb 16 (Reuters) - Great Point Partners LLC: * GREAT POINT PARTNERS LLC OPPOSES THE BIOCRYST PHARMACEUTICAL PROPOSED MERGER WITH IDERA PHARMACEUTICALS, INC. * ‍GREAT POINT PARTNERS, LLC SAYS BENEFICIALLY OWNING ABOUT 7.5 MILLION SHARES OF COMMON STOCK OF BIOCRYST PHARMACEUTICALS​ * GREAT POINT PARTNERS SAYS BELIEVE BIOCRYST PHARMA‘S SHARES ARE “UNDERVALUED” * GREAT POINT PARTNERS SAYS BELIEVE IT IS “INCUMBENT” UPON BIOCRYST PHARMACEUTICAL BOARD TO EXPLORE ALTERNATIVE STRATEGIES Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-16T21:33:00.000+02:00", "crawled": "2018-02-16T21:52:50.010+02:00", "highlightTitle": ""}